Seeing Machines Regulatory News (SEE)

Seeing Machines Limited

("Seeing Machines" or the "Company")

Result of AGM 2012

Seeing Machines Limited (AIM: SEE), the AIM-listed technology company with a focus on vision based human machine interfaces, is pleased to announce that the resolution to re-elect Terry Winters as a director was passed at its Annual General Meeting held today. It also announces that the resolution to re-elect Rob Sale as a director was not passed. Accordingly, Rob Sale ceases to be a director of the Company forthwith.

A copy of the slide presentation made at the Annual General Meeting is available on the Company's website at: http://www.seeingmachines.com/wp-content/uploads/2012/11/Seeing-Machines-AGM-28-November-2012-Final.pdf

Enquiries:

About Seeing Machines Limited

Seeing Machines is a world leader in the development of premier products and applications that rely on capturing and understanding the behaviour of human faces and eyes. More information is available from our web site: www.seeingmachines.com

About Seeing Machines' Driver Safety Solution (DSS)

The Seeing Machines DSS suite is a rugged, non-invasive platform that uses cutting edge face and eye tracking techniques to deliver information on operator fatigue and distraction. The DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment and therefore need to be monitored and managed.

For more information on DSS, go to http://www.seeingmachines.com/product/dss/

About Seeing Machines' Fatigue Management Consulting

Seeing Machines supports its DSS technology with professional and scientific fatigue management consulting and training services designed to build understanding of how businesses can reduce the risk of operator fatigue and support the readiness, implementation and acceptance of its products. Seeing Machines has developed a comprehensive fatigue management framework through combined collaboration with leading fatigue research institutions and hands on experience in the field with organisations who proactively manage fatigue. Seeing Machines also provides detailed fatigue management training for site personnel to better enable them to understand the causes of, and manage their own fatigue. For more information on fatigue management, go to http://www.seeingmachines.com/fatigue-consultancy/

About Seeing Machines' faceAPI®

faceAPI® allows users to incorporate Seeing Machines world-class face tracking technology into their own products or applications. faceAPI provides a growing suite of image-processing modules created specifically for tracking and understanding faces and facial features. These powerful tracking modules are combined into a complete API toolkit that delivers a rich stream of information that can be incorporated into our customers' own products or services. Seeing Machines faceAPI® delivers a comprehensive, integrated solution for developing products that leverage real-time face tracking. All image-processing for face tracking is handled internally, removing the need for computer vision experience. For more information on faceAPI®, go to http://www.seeingmachines.com/product/faceapi/

About Seeing Machines' faceLAB®5

Seeing Machines has been creating advanced eye tracking algorithms since the company was founded in 2000. faceLAB®5 is the organisation's eye tracking system that allows researchers to objectively measure human behavior in a wide range of operational conditions and research settings. faceLAB®'s unique eye and facial tracking solution offers users rare flexibility, portability, and accuracy. For more information on faceLAB®, go to http://www.seeingmachines.com/product/facelab/

About Seeing Machines' Truefield® Analyzer (TFA)

Currently going through its final clinical trials, the TFA will make objective visual field testing a clinical reality. It combines objectivity with 'non-contact' ease of use, making it easy for technicians and patients, giving clinicians objectivity when assessing their patients' conditions. Assessing both eyes concurrently, TFA tests are fast and can be run in both full-test and screening modes. The tests' bilateral concurrency allows the consensual light reflex to be exploited to identify bilateral asymmetries improving test accuracy. Most importantly, the TFA makes objective perimetry a clinical reality. For more information on TFA, go to http://www.seeingmachines.com/product/truefield/